Kiniksa Pharmaceuticals International, plc Operating Margin in % from 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Kiniksa Pharmaceuticals International, plc quarterly/annual Operating Margin history and growth rate from 2022 to Q3 2025.
  • Kiniksa Pharmaceuticals International, plc Operating Margin for the quarter ending September 30, 2025 was 6.38 %.
  • Kiniksa Pharmaceuticals International, plc annual Operating Margin for 2024 was -10.8 %, a 15.6% decline from 2023.
  • Kiniksa Pharmaceuticals International, plc annual Operating Margin for 2023 was -9.32 %, a 310% decline from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)

Kiniksa Pharmaceuticals International, plc Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 6.38 +13.2 Jul 1, 2025 Sep 30, 2025
Q2 2025 0.85 +8.96 Apr 1, 2025 Jun 30, 2025
Q1 2025 -3.28 +6.84 +67.6% Jan 1, 2025 Mar 31, 2025
Q4 2024 -10.8 -1.45 -15.6% Oct 1, 2024 Dec 31, 2024
Q3 2024 -6.83 +0.9 +11.6% Jul 1, 2024 Sep 30, 2024
Q2 2024 -8.12 -21.7 -160% Apr 1, 2024 Jun 30, 2024
Q1 2024 -10.1 -19.4 -209% Jan 1, 2024 Mar 31, 2024
Q4 2023 -9.32 -13.8 -310% Oct 1, 2023 Dec 31, 2023
Q3 2023 -7.73 Jul 1, 2023 Sep 30, 2023
Q2 2023 13.6 Apr 1, 2023 Jun 30, 2023
Q1 2023 9.26 Jan 1, 2023 Mar 31, 2023
Q4 2022 4.44 Oct 1, 2022 Dec 31, 2022

Kiniksa Pharmaceuticals International, plc Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -10.8 -1.45 -15.6% Jan 1, 2024 Dec 31, 2024
2023 -9.32 -13.8 -310% Jan 1, 2023 Dec 31, 2023
2022 4.44 Jan 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.